Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors

References

• Daeron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, Fridman WH. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 1995; 3:635-46; PMID:7584153; http://dx.doi.org/10.1016/1074-7613(95)90134-5
   PubMed Web of Science ®Google Scholar
• Staub E, Rosenthal A, Hinzmann B. Systematic identification of immunoreceptor tyrosine-based inhibitory motifs in the human proteome. Cell Signal 2004; 16:435-56; PMID:14709333; http://dx.doi.org/10.1016/j.cellsig.2003.08.013
   PubMed Web of Science ®Google Scholar
• Takai T, Nakamura A, Endo S. Role of PIR-B in autoimmune glomerulonephritis. J Biomed Biotechnol 2011; 2011:275302; PMID:20976309; http://dx.doi.org/10.1155/2011/275302
   PubMed Web of Science ®Google Scholar
• Daeron M, Jaeger S, Du Pasquier L, Vivier E. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol Rev 2008; 224:11-43; PMID:18759918; http://dx.doi.org/10.1111/j.1600-065X.2008.00666.x
   PubMed Web of Science ®Google Scholar
• Katz HR. Inhibition of inflammatory responses by leukocyte Ig-like receptors. Adv Immunol 2006; 91:251-72; PMID:16938543; http://dx.doi.org/10.1016/S0065-2776(06)91007-4
   PubMed Web of Science ®Google Scholar
• Bruhns P, Vely F, Malbec O, Fridman WH, Vivier E, Daeron M. Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by fcgamma RIIB. J Biol Chem 2000; 275:37357-64; PMID:11016922; http://dx.doi.org/10.1074/jbc.M003518200
   PubMed Web of Science ®Google Scholar
• Huang ZY, Hunter S, Kim MK, Indik ZK, Schreiber AD. The effect of phosphatases SHP-1 and SHIP-1 on signaling by the ITIM- and ITAM-containing Fcgamma receptors FcgammaRIIB and FcgammaRIIA. J Leukocyte Biol 2003; 73:823-9; PMID:12773515; http://dx.doi.org/10.1189/jlb.0902454
   PubMed Web of Science ®Google Scholar
• Binstadt BA, Brumbaugh KM, Dick CJ, Scharenberg AM, Williams BL, Colonna M, Lanier LL, Kinet JP, Abraham RT, Leibson PJ. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 1996; 5:629-38; PMID:8986721; http://dx.doi.org/10.1016/S1074-7613(00)80276-9
   PubMed Web of Science ®Google Scholar
• Daigle I, Yousefi S, Colonna M, Green DR, Simon HU. Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat Med 2002; 8:61-7; PMID:11786908; http://dx.doi.org/10.1038/nm0102-61
   PubMed Web of Science ®Google Scholar
• Stebbins CC, Watzl C, Billadeau DD, Leibson PJ, Burshtyn DN, Long EO. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol 2003; 23:6291-9; PMID:12917349; http://dx.doi.org/10.1128/MCB.23.17.6291-6299.2003
   PubMed Web of Science ®Google Scholar
• Ivashkiv LB. Cross-regulation of signaling by ITAM-associated receptors. Nat Immunol 2009; 10:340-7; PMID:19295630; http://dx.doi.org/10.1038/ni.1706
   PubMed Web of Science ®Google Scholar
• Borges L, Hsu ML, Fanger N, Kubin M, Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol (Baltimore, Md : 1950) 1997; 159:5192-6; PMID:9548455
   PubMed Web of Science ®Google Scholar
• Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Samaridis J, Angman L, Cella M, Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997; 186:1809-18; PMID:9382880; http://dx.doi.org/10.1084/jem.186.11.1809
   PubMed Web of Science ®Google Scholar
• Cella M, Dohring C, Samaridis J, Dessing M, Brockhaus M, Lanzavecchia A, Colonna M. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med 1997; 185:1743-51; PMID:9151699; http://dx.doi.org/10.1084/jem.185.10.1743
   PubMed Web of Science ®Google Scholar
• Samaridis J, Colonna M. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol 1997; 27:660-5; PMID:9079806; http://dx.doi.org/10.1002/eji.1830270313
   PubMed Web of Science ®Google Scholar
• Martin AM, Kulski JK, Witt C, Pontarotti P, Christiansen FT. Leukocyte Ig-like receptor complex (LRC) in mice and men. Trend Immunol 2002; 23:81-8; PMID:11929131; http://dx.doi.org/10.1016/S1471-4906(01)02155-X
   PubMed Web of Science ®Google Scholar
• Wende H, Colonna M, Ziegler A, Volz A. Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4. Mammalian Gen 1999; 10:154-60; PMID:9922396; http://dx.doi.org/10.1007/s003359900961
   PubMed Web of Science ®Google Scholar
• Kubagawa H, Burrows PD, Cooper MD. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci U S A 1997; 94:5261-6; PMID:9144225; http://dx.doi.org/10.1073/pnas.94.10.5261
   PubMed Web of Science ®Google Scholar
• Katz HR, Vivier E, Castells MC, McCormick MJ, Chambers JM, Austen KF. Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor for IgE. Proc Natl Acad Sci U S A 1996; 93:10809-14; PMID:8855262; http://dx.doi.org/10.1073/pnas.93.20.10809
   PubMed Web of Science ®Google Scholar
• Mori Y, Tsuji S, Inui M, Sakamoto Y, Endo S, Ito Y, Fujimura S, Koga T, Nakamura A, Takayanagi H, et al. Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development. J Immunol 2008; 181:4742-51; PMID:18802077; http://dx.doi.org/10.4049/jimmunol.181.7.4742
   PubMed Web of Science ®Google Scholar
• Zheng J, Umikawa M, Cui C, Li J, Chen X, Zhang C, Hyunh H, Kang X, Silvany R, Wan X, et al. Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. Nature 2012; 485:656-60; PMID:22660330; http://dx.doi.org/10.1038/nature11095
   PubMed Web of Science ®Google Scholar
• Deng M, Lu Z, Zheng J, Wan X, Chen X, Hirayasu K, Sun H, Lam Y, Chen L, Wang Q, et al. A motif in LILRB2 critical for Angptl2 binding and activation. Blood 2014; 124:924-35; PMID:24899623; http://dx.doi.org/10.1182/blood-2014-01-549162
   PubMed Web of Science ®Google Scholar
• Atwal JK, Pinkston-Gosse J, Syken J, Stawicki S, Wu Y, Shatz C, Tessier-Lavigne M. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 2008; 322:967-70; PMID:18988857; http://dx.doi.org/10.1126/science.1161151
   PubMed Web of Science ®Google Scholar
• Kim T, Vidal GS, Djurisic M, William CM, Birnbaum ME, Garcia KC, Hyman BT, Shatz CJ. Human LilrB2 is a beta-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model. Science 2013; 341:1399-404; PMID:24052308; http://dx.doi.org/10.1126/science.1242077
   PubMed Web of Science ®Google Scholar
• Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 2015; 161:205-14; PMID:25860605; http://dx.doi.org/10.1016/j.cell.2015.03.030
   PubMed Web of Science ®Google Scholar
• Carosella ED, Rouas-Freiss N, Roux DT, Moreau P, LeMaoult J. HLA-G: An Immune Checkpoint Molecule. Adv Immunol 2015; 127:33-144; PMID:26073983; http://dx.doi.org/10.1016/bs.ai.2015.04.001
   PubMed Web of Science ®Google Scholar
• Olde Nordkamp MJ, van Eijk M, Urbanus RT, Bont L, Haagsman HP, Meyaard L. Leukocyte-associated Ig-like receptor-1 is a novel inhibitory receptor for surfactant protein D. J Leukoc Biol 2014; 96:105-11; PMID:24585933; http://dx.doi.org/10.1189/jlb.3AB0213-092RR
   PubMed Web of Science ®Google Scholar
• Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, Lanier LL, Phillips JH. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 1997; 7:283-90; PMID:9285412; http://dx.doi.org/10.1016/S1074-7613(00)80530-0
   PubMed Web of Science ®Google Scholar
• Poggi A, Pella N, Morelli L, Spada F, Revello V, Sivori S, Augugliaro R, Moretta L, Moretta A. p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. Eur J Immunol 1995; 25:369-76; PMID:7875198; http://dx.doi.org/10.1002/eji.1830250210
   PubMed Web of Science ®Google Scholar
• Lebbink RJ, de Ruiter T, Adelmeijer J, Brenkman AB, van Helvoort JM, Koch M, Farndale RW, Lisman T, Sonnenberg A, Lenting PJ, et al. Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med 2006; 203:1419-25; PMID:16754721; http://dx.doi.org/10.1084/jem.20052554
   PubMed Web of Science ®Google Scholar
• Kang X, Lu Z, Cui C, Deng M, Fan Y, Dong B, Han X, Xie F, Tyner JW, Coligan JE, et al. The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development. Nat Cell Biol 2015; 17:665-77; PMID:25915125; http://dx.doi.org/10.1038/ncb3158
   PubMed Web of Science ®Google Scholar
• Liu X, Yu X, Xie J, Zhan M, Yu Z, Xie L, Zeng H, Zhang F, Chen G, Yi X, et al. ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells. Oncotarget 2015;
   Google Scholar
• Wang L, Geng T, Guo X, Liu J, Zhang P, Yang D, Li J, Yu S, Sun Y. Co-expression of immunoglobulin-like transcript 4 and angiopoietin-like proteins in human non-small cell lung cancer. Mol Med Rep 2015; 11:2789-96; PMID:25482926
   PubMed Web of Science ®Google Scholar
• Zhang P, Yu S, Li H, Liu C, Li J, Lin W, Gao A, Wang L, Gao W, Sun Y. ILT4 drives B7-H3 expression via PI3K/AKT/mTOR signalling and ILT4/B7-H3 co-expression correlates with poor prognosis in non-small cell lung cancer. FEBS Lett 2015; 589:2248-56; PMID:26149216
   PubMed Web of Science ®Google Scholar
• Naji A, Menier C, Maki G, Carosella ED, Rouas-Freiss N. Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction. Leukemia 2012; 26:1889-92; PMID:22441169; http://dx.doi.org/10.1038/leu.2012.62
   PubMed Web of Science ®Google Scholar
• Harly C, Peyrat MA, Netzer S, Dechanet-Merville J, Bonneville M, Scotet E. Up-regulation of cytolytic functions of human Vdelta2-gamma T lymphocytes through engagement of ILT2 expressed by tumor target cells. Blood 2011; 117:2864-73; PMID:21233315; http://dx.doi.org/10.1182/blood-2010-09-309781
   PubMed Web of Science ®Google Scholar
• Urosevic M, Kamarashev J, Burg G, Dummer R. Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2. Blood 2004; 103:1796-8; PMID:14592815; http://dx.doi.org/10.1182/blood-2003-10-3372
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lu N, Xue Y, Zhang M, Li Y, Si Y, Bian X, Jia Y, Wang Y. Expression of immunoglobulin-like transcript (ILT)2 and ILT3 in human gastric cancer and its clinical significance. Mol Med Rep 2012; 5:910-6; PMID:22246571
   PubMed Web of Science ®Google Scholar
• Heidenreich S, Zu Eulenburg C, Hildebrandt Y, Stubig T, Sierich H, Badbaran A, Eiermann TH, Binder TM, Kroger N. Impact of the NK cell receptor LIR-1 (ILT-2/CD85j/LILRB1) on cytotoxicity against multiple myeloma. Clin Dev Immunol 2012; 2012:652130; PMID:22844324; http://dx.doi.org/10.1155/2012/652130
   PubMedGoogle Scholar
• Colovai AI, Tsao L, Wang S, Lin H, Wang C, Seki T, Fisher JG, Menes M, Bhagat G, Alobeid B, et al. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia. Cytometry B Clin Cytom 2007; 72:354-62; PMID:17266150; http://dx.doi.org/10.1002/cyto.b.20164
   PubMed Web of Science ®Google Scholar
• Liu J, Wang L, Gao W, Li L, Cui X, Yang H, Lin W, Dang Q, Zhang N, Sun Y. Inhibitory receptor immunoglobulin-like transcript 4 was highly expressed in primary ductal and lobular breast cancer and significantly correlated with IL-10. Diagn Pathol 2014; 9:85; PMID:24762057; http://dx.doi.org/10.1186/1746-1596-9-85
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu J, Gao P, Wang Y, Liu C. Expression of Ig-like transcript 4 inhibitory receptor in human non-small cell lung cancer. Chest 2008; 134:783-8; PMID:18625675; http://dx.doi.org/10.1378/chest.07-1100
   PubMed Web of Science ®Google Scholar
• Pfistershammer K, Lawitschka A, Klauser C, Leitner J, Weigl R, Heemskerk MH, Pickl WF, Majdic O, Bohmig GA, Fischer GF, et al. Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients. Blood 2009; 114:2323-32; PMID:19617579; http://dx.doi.org/10.1182/blood-2008-10-183814
   PubMed Web of Science ®Google Scholar
• Suciu-Foca N, Feirt N, Zhang QY, Vlad G, Liu Z, Lin H, Chang CC, Ho EK, Colovai AI, Kaufman H, et al. Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients. J Immunol 2007; 178:7432-41; PMID:17513794; http://dx.doi.org/10.4049/jimmunol.178.11.7432
   PubMed Web of Science ®Google Scholar
• Cortesini R. Pancreas cancer and the role of soluble immunoglobulin-like transcript 3 (ILT3). JOP 2007; 8:697-703; PMID:17993722
   PubMedGoogle Scholar
• Chen Z, Shojaee S, Buchner M, Geng H, Lee JW, Klemm L, Titz B, Graeber TG, Park E, Tan YX, et al. Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. Nature 2015; 521:357-61; PMID:25799995; http://dx.doi.org/10.1038/nature14231
   PubMed Web of Science ®Google Scholar
• Ma G, Pan PY, Eisenstein S, Divino CM, Lowell CA, Takai T, Chen SH. Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 2011; 34:385-95; PMID:21376641; http://dx.doi.org/10.1016/j.immuni.2011.02.004
   PubMed Web of Science ®Google Scholar
• Hirayasu K, Arase H. Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations. J Hum Gen 2015; PMID:26040207
   PubMed Web of Science ®Google Scholar
• Barrow AD, Trowsdale J. The extended human leukocyte receptor complex: diverse ways of modulating immune responses. Immunol Rev 2008; 224:98-123; PMID:18759923; http://dx.doi.org/10.1111/j.1600-065X.2008.00653.x
   PubMed Web of Science ®Google Scholar
• Trowsdale J, Jones DC, Barrow AD, Traherne JA. Surveillance of cell and tissue perturbation by receptors in the LRC. Immunol Rev 2015; 267:117-36; PMID:26284474; http://dx.doi.org/10.1111/imr.12314
   PubMed Web of Science ®Google Scholar
• Willcox BE, Thomas LM, Bjorkman PJ. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol 2003; 4:913-9; PMID:12897781; http://dx.doi.org/10.1038/ni961
   PubMed Web of Science ®Google Scholar
• Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA, Dunbar R, Ogg GS, Cerundolo V, Rolink A. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol (Baltimore, Md : 1950) 1998; 160:3096-100; PMID:9531263
   PubMed Web of Science ®Google Scholar
• Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, Allan DS, Makadzange A, Rowland-Jones S, Willcox B, et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A 2003; 100:8856-61; PMID:12853576; http://dx.doi.org/10.1073/pnas.1431057100
   PubMed Web of Science ®Google Scholar
• Zhang Z, Hatano H, Shaw J, Olde Nordkamp M, Jiang G, Li D, Kollnberger S. The Leukocyte Immunoglobulin-Like Receptor Family Member LILRB5 Binds to HLA-Class I Heavy Chains. PLoS One 2015; 10:e0129063; PMID:26098415; http://dx.doi.org/10.1371/journal.pone.0129063
   PubMed Web of Science ®Google Scholar
• Fridman WH. Fc receptors and immunoglobulin binding factors. FASEB J 1991; 5:2684-90; PMID:1916092
   PubMed Web of Science ®Google Scholar
• Li D, Wang L, Yu L, Freundt EC, Jin B, Screaton GR, Xu XN. Ig-like transcript 4 inhibits lipid antigen presentation through direct CD1d interaction. J Immunol 2009; 182:1033-40; PMID:19124746; http://dx.doi.org/10.4049/jimmunol.182.2.1033
   PubMed Web of Science ®Google Scholar
• Arnold V, Cummings JS, Moreno-Nieves UY, Didier C, Gilbert A, Barre-Sinoussi F, Scott-Algara D. S100A9 protein is a novel ligand for the CD85j receptor and its interaction is implicated in the control of HIV-1 replication by NK cells. Retrovirology 2013; 10:122; PMID:24156302; http://dx.doi.org/10.1186/1742-4690-10-122
   PubMed Web of Science ®Google Scholar
• Torii I, Oka S, Hotomi M, Benjamin WH, Jr., Takai T, Kearney JF, Briles DE, Kubagawa H. PIR-B-deficient mice are susceptible to Salmonella infection. J Immunol 2008; 181:4229-39; http://dx.doi.org/10.4049/jimmunol.181.6.4229
   PubMed Web of Science ®Google Scholar
• Takai T. Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 2005; 115:433-40; PMID:16011512; http://dx.doi.org/10.1111/j.1365-2567.2005.02177.x
   PubMed Web of Science ®Google Scholar
• Castells MC, Klickstein LB, Hassani K, Cumplido JA, Lacouture ME, Austen KF, Katz HR. gp49B1-alpha(v)beta3 interaction inhibits antigen-induced mast cell activation. Nat Immunol 2001; 2:436-42; PMID:11323698
   PubMed Web of Science ®Google Scholar
• Dobrowolska H, Gill KZ, Serban G, Ivan E, Li Q, Qiao P, Suciu-Foca N, Savage D, Alobeid B, Bhagat G, et al. Expression of immune inhibitory receptor ILT3 in acute myeloid leukemia with monocytic differentiation. Cytometry B Clin Cytom 2013; 84:21-9; PMID:23027709; http://dx.doi.org/10.1002/cyto.b.21050
   PubMed Web of Science ®Google Scholar
• Blery M, Kubagawa H, Chen CC, Vely F, Cooper MD, Vivier E. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc Natl Acad Sci U S A 1998; 95:2446-51; PMID:9482905; http://dx.doi.org/10.1073/pnas.95.5.2446
   PubMed Web of Science ®Google Scholar
• Rojo S, Stebbins CC, Peterson ME, Dombrowicz D, Wagtmann N, Long EO. Natural killer cells and mast cells from gp49B null mutant mice are functional. Mol Cell Biol 2000; 20:7178-82; PMID:10982834; http://dx.doi.org/10.1128/MCB.20.19.7178-7182.2000
   PubMed Web of Science ®Google Scholar
• Mitsuhashi Y, Nakamura A, Endo S, Takeda K, Yabe-Wada T, Nukiwa T, Takai T. Regulation of plasmacytoid dendritic cell responses by PIR-B. Blood 2012; 120:3256-9; PMID:22948046; http://dx.doi.org/10.1182/blood-2012-03-419093
   PubMed Web of Science ®Google Scholar
• Tang X, Tian L, Esteso G, Choi SC, Barrow AD, Colonna M, Borrego F, Coligan JE. Leukocyte-associated Ig-like receptor-1-deficient mice have an altered immune cell phenotype. J Immunol 2012; 188:548-58; PMID:22156345; http://dx.doi.org/10.4049/jimmunol.1102044
   PubMed Web of Science ®Google Scholar
• Hunt JS, Petroff MG, Morales P, Sedlmayr P, Geraghty DE, Ober C. HLA-G in reproduction: studies on the maternal-fetal interface. Human immunology 2000; 61:1113-7; PMID:11137215; http://dx.doi.org/10.1016/S0198-8859(00)00195-6
   PubMed Web of Science ®Google Scholar
• Tedla N, Lee CW, Borges L, Geczy CL, Arm JP. Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells. J Leukoc Biol 2008; 83:334-43; PMID:17998301; http://dx.doi.org/10.1189/jlb.0507314
   PubMed Web of Science ®Google Scholar
• Davidson CL, Li NL, Burshtyn DN. LILRB1 polymorphism and surface phenotypes of natural killer cells. Hum Immunol 2010; 71:942-9; PMID:20600445; http://dx.doi.org/10.1016/j.humimm.2010.06.015
   PubMed Web of Science ®Google Scholar
• Lamar DL, Weyand CM, Goronzy JJ. Promoter choice and translational repression determine cell type-specific cell surface density of the inhibitory receptor CD85j expressed on different hematopoietic lineages. Blood 2010; 115:3278-86; PMID:20194892; http://dx.doi.org/10.1182/blood-2009-09-243493
   PubMed Web of Science ®Google Scholar
• Lepin EJ, Bastin JM, Allan DS, Roncador G, Braud VM, Mason DY, van der Merwe PA, McMichael AJ, Bell JI, Powis SH, et al. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur J Immunol 2000; 30:3552-61; PMID:11169396; http://dx.doi.org/10.1002/1521-4141(200012)30:12%3c3552::AID-IMMU3552%3e3.0.CO;2-L
   PubMed Web of Science ®Google Scholar
• Allan DS, Lepin EJ, Braud VM, O'Callaghan CA, McMichael AJ. Tetrameric complexes of HLA-E, HLA-F, and HLA-G. J Immun Methods 2002; 268:43-50; PMID:12213342; http://dx.doi.org/10.1016/S0022-1759(02)00199-0
   PubMed Web of Science ®Google Scholar
• Shiroishi M, Kuroki K, Ose T, Rasubala L, Shiratori I, Arase H, Tsumoto K, Kumagai I, Kohda D, Maenaka K. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem 2006; 281:10439-47; PMID:16455647; http://dx.doi.org/10.1074/jbc.M512305200
   PubMed Web of Science ®Google Scholar
• Chapman TL, Heikeman AP, Bjorkman PJ. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 1999; 11:603-13; PMID:10591185; http://dx.doi.org/10.1016/S1074-7613(00)80135-1
   PubMed Web of Science ®Google Scholar
• Chapman TL, Heikema AP, West AP, Jr., Bjorkman PJ. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity 2000; 13:727-36; PMID:11114384; http://dx.doi.org/10.1016/S1074-7613(00)00071-6
   PubMed Web of Science ®Google Scholar
• Allen RL, Raine T, Haude A, Trowsdale J, Wilson MJ. Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J Immunol 2001; 167:5543-7; http://dx.doi.org/10.4049/jimmunol.167.10.5543
   PubMed Web of Science ®Google Scholar
• Vitale M, Castriconi R, Parolini S, Pende D, Hsu ML, Moretta L, Cosman D, Moretta A. The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones. Inter Immunol 1999; 11:29-35; PMID:10050671; http://dx.doi.org/10.1093/intimm/11.1.29
   PubMed Web of Science ®Google Scholar
• Navarro F, Llano M, Bellon T, Colonna M, Geraghty DE, Lopez-Botet M. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 1999; 29:277-83; PMID:9933109; http://dx.doi.org/10.1002/(SICI)1521-4141(199901)29:01%3c277::AID-IMMU277%3e3.0.CO;2-4
   PubMed Web of Science ®Google Scholar
• Morel E, Bellón T. HLA class I molecules regulate IFN-γ production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j. J Immunol 2008; 181:2368-81; PMID:18684926; http://dx.doi.org/10.4049/jimmunol.181.4.2368
   PubMed Web of Science ®Google Scholar
• LeMaoult J, Zafaranloo K, Le Danff C, Carosella ED. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 2005; 19:662-4; PMID:15670976
   PubMed Web of Science ®Google Scholar
• Favier B, Lemaoult J, Lesport E, Carosella ED. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse. FASEB J 2010; 24:689-99; PMID:19841038; http://dx.doi.org/10.1096/fj.09-135194
   PubMed Web of Science ®Google Scholar
• Ponte M, Cantoni C, Biassoni R, Tradori-Cappai A, Bentivoglio G, Vitale C, Bertone S, Moretta A, Moretta L, Mingari MC. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci U S A 1999; 96:5674-9; PMID:10318943; http://dx.doi.org/10.1073/pnas.96.10.5674
   PubMed Web of Science ®Google Scholar
• Petroff MG, Sedlmayr P, Azzola D, Hunt JS. Decidual macrophages are potentially susceptible to inhibition by class Ia and class Ib HLA molecules. J Reproduct Immunol 2002; 56:3-17; PMID:12106880; http://dx.doi.org/10.1016/S0165-0378(02)00024-4
   PubMed Web of Science ®Google Scholar
• Mamessier E, Sylvain A, Thibult ML, Houvenaeghel G, Jacquemier J, Castellano R, Goncalves A, Andre P, Romagne F, Thibault G, et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest 2011; 121:3609-22; PMID:21841316; http://dx.doi.org/10.1172/JCI45816
   PubMed Web of Science ®Google Scholar
• Roberti MP, Juliá EP, Rocca YS, Amat M, Bravo AI, Loza J, Coló F, Loza CM, Fabiano V, Maino M. Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade. Eur J Immunol 2015; 45:1560-9; PMID:25726929; http://dx.doi.org/10.1002/eji.201445353
   PubMed Web of Science ®Google Scholar
• Kirwan SE, Burshtyn DN. Killer cell Ig-like receptor-dependent signaling by Ig-like transcript 2 (ILT2/CD85j/LILRB1/LIR-1). J Immunol 2005; 175:5006-15; http://dx.doi.org/10.4049/jimmunol.175.8.5006
   PubMed Web of Science ®Google Scholar
• Godal R, Bachanova V, Gleason M, McCullar V, Yun GH, Cooley S, Verneris MR, McGlave PB, Miller JS. Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade. Biol Blood Marrow Trans 2010; 16:612-21; PMID:20139023; http://dx.doi.org/10.1016/j.bbmt.2010.01.019
   PubMed Web of Science ®Google Scholar
• Li C, Houser BL, Nicotra ML, Strominger JL. HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. Proc Natl Acad Sci U S A 2009; 106:5767-72; PMID:19304799; http://dx.doi.org/10.1073/pnas.0901173106
   PubMed Web of Science ®Google Scholar
• Scott-Algara D, Arnold V, Didier C, Kattan T, Pirozzi G, Barre-Sinoussi F, Pancino G. The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cells. PloS one 2008; 3:e1975; PMID:18398485; http://dx.doi.org/10.1371/journal.pone.0001975
   PubMed Web of Science ®Google Scholar
• Fanger NA, Cosman D, Peterson L, Braddy SC, Maliszewski CR, Borges L. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur J Immunol 1998; 28:3423-34; PMID:9842885; http://dx.doi.org/10.1002/(SICI)1521-4141(199811)28:11%3c3423::AID-IMMU3423%3e3.0.CO;2-2
   PubMed Web of Science ®Google Scholar
• Lombardelli L, Aguerre-Girr M, Logiodice F, Kullolli O, Casart Y, Polgar B, Berrebi A, Romagnani S, Maggi E, Le Bouteiller P. HLA-G5 induces IL-4 secretion critical for successful pregnancy through differential expression of ILT2 receptor on decidual CD4+ T cells and macrophages. J Immunol 2013; 191:3651-62; PMID:23997222; http://dx.doi.org/10.4049/jimmunol.1300567
   PubMed Web of Science ®Google Scholar
• Lefebvre S, Antoine M, Uzan S, McMaster M, Dausset J, Carosella ED, Paul P. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J Pathol 2002; 196:266-74; PMID:11857488; http://dx.doi.org/10.1002/path.1039
   PubMed Web of Science ®Google Scholar
• Ju XS, Hacker C, Scherer B, Redecke V, Berger T, Schuler G, Wagner H, Lipford GB, Zenke M. Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation. Gene 2004; 331:159-64; PMID:15094202; http://dx.doi.org/10.1016/j.gene.2004.02.018
   PubMed Web of Science ®Google Scholar
• Young NT, Waller EC, Patel R, Roghanian A, Austyn JM, Trowsdale J. The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells. Blood 2008; 111:3090-6; PMID:18094328; http://dx.doi.org/10.1182/blood-2007-05-089771
   PubMed Web of Science ®Google Scholar
• Fedoric B, Krishnan R. Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction. Immunol Lett 2008; 120:49-56; PMID:18652845; http://dx.doi.org/10.1016/j.imlet.2008.06.009
   PubMed Web of Science ®Google Scholar
• Tenca C, Merlo A, Merck E, Bates EE, Saverino D, Simone R, Zarcone D, Trinchieri G, Grossi CE, Ciccone E. CD85j (leukocyte Ig-like receptor-1/Ig-like transcript 2) inhibits human osteoclast-associated receptor-mediated activation of human dendritic cells. J Immunol 2005; 174:6757-63; http://dx.doi.org/10.4049/jimmunol.174.11.6757
   PubMed Web of Science ®Google Scholar
• Apps R, Gardner L, Sharkey AM, Holmes N, Moffett A. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1. Eur J Immunol 2007; 37:1924-37; PMID:17549736; http://dx.doi.org/10.1002/eji.200737089
   PubMed Web of Science ®Google Scholar
• Monsivais-Urenda A, Gomez-Martin D, Santana-de-Anda K, Cruz-Martinez J, Alcocer-Varela J, Gonzalez-Amaro R. Defective expression and function of the ILT2/CD85j regulatory receptor in dendritic cells from patients with systemic lupus erythematosus. Hum Immunol 2013; 74:1088-96; PMID:23756160; http://dx.doi.org/10.1016/j.humimm.2013.05.006
   PubMed Web of Science ®Google Scholar
• Huang J, Burke PS, Cung TD, Pereyra F, Toth I, Walker BD, Borges L, Lichterfeld M, Yu XG. Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers. J Virol 2010; 84:9463-71; PMID:20631139; http://dx.doi.org/10.1128/JVI.01009-10
   PubMed Web of Science ®Google Scholar
• Banham AH, Colonna M, Cella M, Micklem KJ, Pulford K, Willis AC, Mason DY. Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily. J Leukocyte Biol 1999; 65:841-5; PMID:10380908
   PubMed Web of Science ®Google Scholar
• Young NT, Uhrberg M, Phillips JH, Lanier LL, Parham P. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J Immunol 2001; 166:3933-41; http://dx.doi.org/10.4049/jimmunol.166.6.3933
   PubMed Web of Science ®Google Scholar
• Saverino D, Fabbi M, Ghiotto F, Merlo A, Bruno S, Zarcone D, Tenca C, Tiso M, Santoro G, Anastasi G, et al. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J Immunol 2000; 165:3742-55; http://dx.doi.org/10.4049/jimmunol.165.7.3742
   PubMed Web of Science ®Google Scholar
• Ince MN, Harnisch B, Xu Z, Lee SK, Lange C, Moretta L, Lederman M, Lieberman J. Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function. Immunology 2004; 112:531-42; PMID:15270723; http://dx.doi.org/10.1046/j.1365-2567.2004.01907.x
   PubMed Web of Science ®Google Scholar
• Saverino D, Merlo A, Bruno S, Pistoia V, Grossi CE, Ciccone E. Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells. J Immunol (Baltimore, Md : 1950) 2002; 168:207-15; PMID:11751964; http://dx.doi.org/10.4049/jimmunol.168.1.207
   PubMed Web of Science ®Google Scholar
• Merlo A, Saverino D, Tenca C, Grossi CE, Bruno S, Ciccone E. CD85/LIR-1/ILT2 and CD152 (Cytotoxic T Lymphocyte Antigen 4) Inhibitory Molecules Down-Regulate the Cytolytic Activity of Human CD4+ T-Cell Clones Specific forMycobacterium tuberculosis. Infect Immun 2001; 69:6022-9; PMID:11553539; http://dx.doi.org/10.1128/IAI.69.10.6022-6029.2001
   PubMed Web of Science ®Google Scholar
• Dietrich J, Cella M, Colonna M. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization. J Immunol 2001; 166:2514-21; PMID:11160312; http://dx.doi.org/10.4049/jimmunol.166.4.2514
   PubMed Web of Science ®Google Scholar
• Zhang W, Liang S, Wu J, Horuzsko A. Human Inhibitory Receptor ILT2 Amplifies CD11b+ Gr1+ Myeloid-Derived Suppressor Cells that Promote Long-Term Survival of Allografts. Transplantation 2008; 86:1125; PMID:18946352; http://dx.doi.org/10.1097/TP.0b013e318186fccd
   PubMed Web of Science ®Google Scholar
• Liang S, Zhang W, Horuzsko A. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function. Eur J Immunol 2006; 36:2457-71; PMID:16897816; http://dx.doi.org/10.1002/eji.200636031
   PubMed Web of Science ®Google Scholar
• Lesport E, Baudhuin J, Sousa S, LeMaoult J, Zamborlini A, Rouas-Freiss N, Carosella ED, Favier B. Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer. Cell Mol Life Sci 2011; 68:3385-99; PMID:21337044; http://dx.doi.org/10.1007/s00018-011-0632-7
   PubMed Web of Science ®Google Scholar
• Saverino D, Ghiotto F, Merlo A, Bruno S, Battini L, Occhino M, Maffei M, Tenca C, Pileri S, Baldi L, et al. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J Immunol 2004; 172:5629-37; http://dx.doi.org/10.4049/jimmunol.172.9.5629
   PubMed Web of Science ®Google Scholar
• Wagner CS, Riise GC, Bergstrom T, Karre K, Carbone E, Berg L. Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection. J Immunol 2007; 178:3536-43; http://dx.doi.org/10.4049/jimmunol.178.6.3536
   PubMed Web of Science ®Google Scholar
• Merlo A, Tenca C, Fais F, Battini L, Ciccone E, Grossi CE, Saverino D. Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes. Clin Diagn Laborat Immunol 2005; 12:705-12; PMID:15939744
   PubMedGoogle Scholar
• Naji A, Menier C, Morandi F, Agaugue S, Maki G, Ferretti E, Bruel S, Pistoia V, Carosella ED, Rouas-Freiss N. Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses. J Immunol 2014; 192:1536-46; http://dx.doi.org/10.4049/jimmunol.1300438
   PubMed Web of Science ®Google Scholar
• Kalmbach Y, Boldt AB, Fendel R, Mordmuller B, Kremsner PG, Kun JF. Increase in annexin V-positive B cells expressing LILRB1/ILT2/CD85j in malaria. Eur Cytokine Net 2006; 17:175-80; PMID:17194637
   PubMed Web of Science ®Google Scholar
• Manavalan JS, Kim-Schulze S, Scotto L, Naiyer AJ, Vlad G, Colombo PC, Marboe C, Mancini D, Cortesini R, Suciu-Foca N. Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Inter Immunol 2004; 16:1055-68; PMID:15226269; http://dx.doi.org/10.1093/intimm/dxh107
   PubMed Web of Science ®Google Scholar
• Masuda A, Nakamura A, Maeda T, Sakamoto Y, Takai T. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. J Exp Med 2007; 204:907-20; PMID:17420263; http://dx.doi.org/10.1084/jem.20060631
   PubMed Web of Science ®Google Scholar
• Manavalan JS, Rossi PC, Vlad G, Piazza F, Yarilina A, Cortesini R, Mancini D, Suciu-Foca N. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol 2003; 11:245-58; PMID:12967778; http://dx.doi.org/10.1016/S0966-3274(03)00058-3
   PubMed Web of Science ®Google Scholar
• Bashirova AA, Martin-Gayo E, Jones DC, Qi Y, Apps R, Gao X, Burke PS, Taylor CJ, Rogich J, Wolinsky S, et al. LILRB2 interaction with HLA class I correlates with control of HIV-1 infection. PLoS genetics 2014; 10:e1004196; PMID:24603468; http://dx.doi.org/10.1371/journal.pgen.1004196
   PubMed Web of Science ®Google Scholar
• Brown DP, Jones DC, Anderson KJ, Lapaque N, Buerki RA, Trowsdale J, Allen RL. The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection. BMC Immunol 2009; 10:56; PMID:19860908; http://dx.doi.org/10.1186/1471-2172-10-56
   PubMed Web of Science ®Google Scholar
• Sloane DE, Tedla N, Awoniyi M, Macglashan DW, Jr., Borges L, Austen KF, Arm JP. Leukocyte immunoglobulin-like receptors: novel innate receptors for human basophil activation and inhibition. Blood 2004; 104:2832-9; PMID:15242876; http://dx.doi.org/10.1182/blood-2004-01-0268
   PubMed Web of Science ®Google Scholar
• Arm JP, Nwankwo C, Austen KF. Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. J Immunol 1997; 159:2342-9
   PubMed Web of Science ®Google Scholar
• Vlad G, Chang CC, Colovai AI, Berloco P, Cortesini R, Suciu-Foca N. Immunoglobulin-like transcript 3: A crucial regulator of dendritic cell function. Hum Immunol 2009; 70:340-4; PMID:19275918; http://dx.doi.org/10.1016/j.humimm.2009.03.004
   PubMed Web of Science ®Google Scholar
• Kim-Schulze S, Seki T, Vlad G, Scotto L, Fan J, Colombo PC, Liu J, Cortesini R, Suciu-Foca N. Regulation of ILT3 gene expression by processing of precursor transcripts in human endothelial cells. Am J Transplant 2006; 6:76-82; PMID:16433759; http://dx.doi.org/10.1111/j.1600-6143.2005.01162.x
   PubMed Web of Science ®Google Scholar
• Chang CC, Silvia EA, Ho EK, Vlad G, Suciu-Foca N, Vasilescu ER. Polymorphism and linkage disequilibrium of immunoglobulin-like transcript 3 g ene. Hum Immunol 2008; 69:284-90; PMID:18486764; http://dx.doi.org/10.1016/j.humimm.2008.02.004
   PubMed Web of Science ®Google Scholar
• Cheng H, Mohammed F, Nam G, Chen Y, Qi J, Garner LI, Allen RL, Yan J, Willcox BE, Gao GF. Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance. J Biol Chem 2011; 286:18013-25; PMID:21454581; http://dx.doi.org/10.1074/jbc.M111.221028
   PubMed Web of Science ®Google Scholar
• Waschbisch A, Sanderson N, Krumbholz M, Vlad G, Theil D, Schwab S, Maurer M, Derfuss T. Interferon beta and vitamin D synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients. PloS one 2014; 9:e115488; PMID:25551576; http://dx.doi.org/10.1371/journal.pone.0115488
   PubMed Web of Science ®Google Scholar
• Lu HK, Rentero C, Raftery MJ, Borges L, Bryant K, Tedla N. Leukocyte Ig-like receptor B4 (LILRB4) is a potent inhibitor of FcgammaRI-mediated monocyte activation via dephosphorylation of multiple kinases. J Biol Chem 2009; 284:34839-48; PMID:19833736; http://dx.doi.org/10.1074/jbc.M109.035683
   PubMed Web of Science ®Google Scholar
• Kim-Schulze S, Scotto L, Vlad G, Piazza F, Lin H, Liu Z, Cortesini R, Suciu-Foca N. Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells. J Immunol 2006; 176:2790-8; PMID:16493035; http://dx.doi.org/10.4049/jimmunol.176.5.2790
   PubMed Web of Science ®Google Scholar
• Vlad G, D'Agati VD, Zhang QY, Liu Z, Ho EK, Mohanakumar T, Hardy MA, Cortesini R, Suciu-Foca N. Immunoglobulin-like transcript 3-Fc suppresses T-cell responses to allogeneic human islet transplants in hu-NOD/SCID mice. Diabetes 2008; 57:1878-86; PMID:18420485; http://dx.doi.org/10.2337/db08-0054
   PubMed Web of Science ®Google Scholar
• Vlad G, Stokes MB, Liu Z, Chang CC, Sondermeijer H, Vasilescu ER, Colovai AI, Berloco P, D'Agati VD, Ratner L, et al. Suppression of xenogeneic graft-versus-host disease by treatment with immunoglobulin-like transcript 3-Fc. Hum Immunol 2009; 70:663-9; PMID:19501624; http://dx.doi.org/10.1016/j.humimm.2009.06.001
   PubMed Web of Science ®Google Scholar
• Chang CC, Liu Z, Vlad G, Qin H, Qiao X, Mancini DM, Marboe CC, Cortesini R, Suciu-Foca N. Ig-like transcript 3 regulates expression of proinflammatory cytokines and migration of activated T cells. J Immunol 2009; 182:5208-16; http://dx.doi.org/10.4049/jimmunol.0804048
   PubMed Web of Science ®Google Scholar
• Chang CC, Vlad G, D'Agati VD, Liu Z, Zhang QY, Witkowski P, Torkamani AA, Stokes MB, Ho EK, Cortesini R, et al. BCL6 is required for differentiation of Ig-like transcript 3-Fc-induced CD8+ T suppressor cells. J Immunol 2010; 185:5714-22; http://dx.doi.org/10.4049/jimmunol.1001732
   PubMed Web of Science ®Google Scholar
• Ulges A, Klein M, Reuter S, Gerlitzki B, Hoffmann M, Grebe N, Staudt V, Stergiou N, Bohn T, Bruhl TJ, et al. Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo. Nat Immunol 2015; 16:267-75; PMID:25599562; http://dx.doi.org/10.1038/ni.3083
   PubMed Web of Science ®Google Scholar
• de Goeje PL, Bezemer K, Heuvers ME, Dingemans AC, Groen HJ, Smit EF, Hoogsteden HC, Hendriks RW, Aerts JG, Hegmans JP. Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer. Oncoimmunology 2015; 4:e1014242; PMID:26140237; http://dx.doi.org/10.1080/2162402X.2015.1014242
   PubMed Web of Science ®Google Scholar
• Khan MF, Bahr JM, Yellapa A, Bitterman P, Abramowicz JS, Edassery SL, Basu S, Rotmensch J, Barua A. Expression of Leukocyte Inhibitory Immunoglobulin-like Transcript 3 Receptors by Ovarian Tumors in Laying Hen Model of Spontaneous Ovarian Cancer. Trans Oncol 2012; 5:85-91; PMID:22496924; http://dx.doi.org/10.1593/tlo.11328
   PubMed Web of Science ®Google Scholar
• Dube MP, Zetler R, Barhdadi A, Brown AM, Mongrain I, Normand V, Laplante N, Asselin G, Zada YF, Provost S, et al. CKM and LILRB5 are associated with serum levels of creatine kinase. Circul Cardiov Gen 2014; 7:880-6; PMID:25214527; http://dx.doi.org/10.1161/CIRCGENETICS.113.000395
   PubMed Web of Science ®Google Scholar
• Maeda A, Kurosaki M, Ono M, Takai T, Kurosaki T. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal. J Exp Med 1998; 187:1355-60; PMID:9547347; http://dx.doi.org/10.1084/jem.187.8.1355
   PubMed Web of Science ®Google Scholar
• Zhao J, Luo Y, Wang X, Zhou H, Li Q, You Y, Zou P. Prevention of murine acute graft-versus-host disease by recipient-derived paired immunoglobulin-like receptor B lentivirus-transfected dendritic cells. Acta Haematol 2010; 124:134-40; PMID:20881379; http://dx.doi.org/10.1159/000315553
   PubMed Web of Science ®Google Scholar
• Ujike A, Takeda K, Nakamura A, Ebihara S, Akiyama K, Takai T. Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. Nat Immunol 2002; 3:542-8; PMID:12021780; http://dx.doi.org/10.1038/ni801
   PubMed Web of Science ®Google Scholar
• Munitz A, Cole ET, Beichler A, Groschwitz K, Ahrens R, Steinbrecher K, Willson T, Han X, Denson L, Rothenberg ME, et al. Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis. Gastroenterol 2010; 139:530-41; PMID:20398663; http://dx.doi.org/10.1053/j.gastro.2010.04.006
   PubMed Web of Science ®Google Scholar
• Karo-Atar D, Moshkovits I, Eickelberg O, Konigshoff M, Munitz A. Paired immunoglobulin-like receptor-B inhibits pulmonary fibrosis by suppressing profibrogenic properties of alveolar macrophages. Am J Resp Cell Mol Biol 2013; 48:456-64; PMID:23258232; http://dx.doi.org/10.1165/rcmb.2012-0329OC
   PubMed Web of Science ®Google Scholar
• Imada M, Masuda K, Satoh R, Ito Y, Goto Y, Matsuoka T, Endo S, Nakamura A, Kawamoto H, Takai T. Ectopically expressed PIR-B on T cells constitutively binds to MHC class I and attenuates T helper type 1 responses. Int Immunol 2009; 21:1151-61; PMID:19684158; http://dx.doi.org/10.1093/intimm/dxp081
   PubMed Web of Science ®Google Scholar
• Munitz A, McBride ML, Bernstein JS, Rothenberg ME. A dual activation and inhibition role for the paired immunoglobulin-like receptor B in eosinophils. Blood 2008; 111:5694-703; PMID:18316626; http://dx.doi.org/10.1182/blood-2007-12-126748
   PubMed Web of Science ®Google Scholar
• Bochner DN, Sapp RW, Adelson JD, Zhang S, Lee H, Djurisic M, Syken J, Dan Y, Shatz CJ. Blocking PirB up-regulates spines and functional synapses to unlock visual cortical plasticity and facilitate recovery from amblyopia. Sci Trans Med 2014; 6:258ra140; http://dx.doi.org/10.1126/scitranslmed.3010157
   PubMed Web of Science ®Google Scholar
• Djurisic M, Vidal GS, Mann M, Aharon A, Kim T, Ferrao Santos A, Zuo Y, Hubener M, Shatz CJ. PirB regulates a structural substrate for cortical plasticity. Proc Natl Acad Sci U S A 2013; 110:20771-6; PMID:24302763; http://dx.doi.org/10.1073/pnas.1321092110
   PubMed Web of Science ®Google Scholar
• Syken J, Grandpre T, Kanold PO, Shatz CJ. PirB restricts ocular-dominance plasticity in visual cortex. Science 2006; 313:1795-800; PMID:16917027; http://dx.doi.org/10.1126/science.1128232
   PubMed Web of Science ®Google Scholar
• Kubagawa H, Chen CC, Ho LH, Shimada TS, Gartland L, Mashburn C, Uehara T, Ravetch JV, Cooper MD. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. J Exp Med 1999; 189:309-18; PMID:9892613; http://dx.doi.org/10.1084/jem.189.2.309
   PubMed Web of Science ®Google Scholar
• Katz HR, LeBlanc PA, Russell SW. Two classes of mouse mast cells delineated by monoclonal antibodies. Proc Natl Acad Sci U S A 1983; 80:5916-8; PMID:6577460; http://dx.doi.org/10.1073/pnas.80.19.5916
   PubMed Web of Science ®Google Scholar
• LeBlanc PA, Biron CA. Mononuclear phagocyte maturation: a cytotoxic monoclonal antibody reactive with postmonoblast stages. Cell Immunol 1984; 83:242-54; PMID:6198098; http://dx.doi.org/10.1016/0008-8749(84)90303-4
   PubMed Web of Science ®Google Scholar
• Zhou JS, Friend DS, Feldweg AM, Daheshia M, Li L, Austen KF, Katz HR. Prevention of lipopolysaccharide-induced microangiopathy by gp49B1: evidence for an important role for gp49B1 expression on neutrophils. J Exp Med 2003; 198:1243-51; PMID:14557414; http://dx.doi.org/10.1084/jem.20030906
   PubMed Web of Science ®Google Scholar
• Wang LL, Chu DT, Dokun AO, Yokoyama WM. Inducible expression of the gp49B inhibitory receptor on NK cells. J Immunol 2000; 164:5215-20; http://dx.doi.org/10.4049/jimmunol.164.10.5215
   PubMed Web of Science ®Google Scholar
• Gu X, Laouar A, Wan J, Daheshia M, Lieberman J, Yokoyama WM, Katz HR, Manjunath N. The gp49B1 inhibitory receptor regulates the IFN-gamma responses of T cells and NK cells. J Immunol 2003; 170:4095-101; http://dx.doi.org/10.4049/jimmunol.170.8.4095
   PubMed Web of Science ®Google Scholar
• Kuroiwa A, Yamashita Y, Inui M, Yuasa T, Ono M, Nagabukuro A, Matsuda Y, Takai T. Association of tyrosine phosphatases SHP-1 and SHP-2, inositol 5-phosphatase SHIP with gp49B1, and chromosomal assignment of the gene. J Biol Chem 1998; 273:1070-4; PMID:9422771; http://dx.doi.org/10.1074/jbc.273.2.1070
   PubMed Web of Science ®Google Scholar
• Wang LL, Blasioli J, Plas DR, Thomas ML, Yokoyama WM. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B. J Immunol 1999; 162:1318-23
   PubMed Web of Science ®Google Scholar
• Lu-Kuo JM, Joyal DM, Austen KF, Katz HR. gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization. J Biol Chem 1999; 274:5791-6; PMID:10026201; http://dx.doi.org/10.1074/jbc.274.9.5791
   PubMed Web of Science ®Google Scholar
• Fukao S, Haniuda K, Nojima T, Takai T, Kitamura D. gp49B-mediated negative regulation of antibody production by memory and marginal zone B cells. J Immunol 2014; 193:635-44; http://dx.doi.org/10.4049/jimmunol.1302772
   PubMed Web of Science ®Google Scholar
• Daheshia M, Friend DS, Grusby MJ, Austen KF, Katz HR. Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice. J Exp Med 2001; 194:227-34; PMID:11457897; http://dx.doi.org/10.1084/jem.194.2.227
   PubMed Web of Science ®Google Scholar
• Feldweg AM, Friend DS, Zhou JS, Kanaoka Y, Daheshia M, Li L, Austen KF, Katz HR. gp49B1 suppresses stem cell factor-induced mast cell activation-secretion and attendant inflammation in vivo. Eur J Immunol 2003; 33:2262-8; PMID:12884301; http://dx.doi.org/10.1002/eji.200323978
   PubMed Web of Science ®Google Scholar
• Zhou JS, Friend DS, Lee DM, Li L, Austen KF, Katz HR. gp49B1 deficiency is associated with increases in cytokine and chemokine production and severity of proliferative synovitis induced by anti-type II collagen mAb. Eur J Immunol 2005; 35:1530-8; PMID:15827966; http://dx.doi.org/10.1002/eji.200425895
   PubMed Web of Science ®Google Scholar
• Breslow RG, Rao JJ, Xing W, Hong DI, Barrett NA, Katz HR. Inhibition of Th2 adaptive immune responses and pulmonary inflammation by leukocyte Ig-like receptor B4 on dendritic cells. J Immunol 2010; 184:1003-13; http://dx.doi.org/10.4049/jimmunol.0900877
   PubMed Web of Science ®Google Scholar
• Fanning LB, Buckley CC, Xing W, Breslow RG, Katz HR. Downregulation of key early events in the mobilization of antigen-bearing dendritic cells by leukocyte immunoglobulin-like Receptor B4 in a mouse model of allergic pulmonary inflammation. PloS One 2013; 8:e57007
   PubMed Web of Science ®Google Scholar
• Minoo P, Zadeh MM, Rottapel R, Lebrun JJ, Ali S. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling. Blood 2004; 103:1398-407; PMID:14551136; http://dx.doi.org/10.1182/blood-2003-07-2617
   PubMed Web of Science ®Google Scholar
• Dance M, Montagner A, Salles JP, Yart A, Raynal P. The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway. Cell Signal 2008; 20:453-9; PMID:17993263; http://dx.doi.org/10.1016/j.cellsig.2007.10.002
   PubMed Web of Science ®Google Scholar
• Meyaard L. LAIR and collagens in immune regulation. Immunol Lett 2010; 128:26-8; PMID:19836418; http://dx.doi.org/10.1016/j.imlet.2009.09.014
   PubMed Web of Science ®Google Scholar
• Perbellini O, Falisi E, Giaretta I, Boscaro E, Novella E, Facco M, Fortuna S, Finotto S, Amati E, Maniscalco F, et al. Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia. Haematologica 2014; 99:881-7; PMID:24415628; http://dx.doi.org/10.3324/haematol.2013.096362
   PubMed Web of Science ®Google Scholar
• Poggi A, Catellani S, Bruzzone A, Caligaris-Cappio F, Gobbi M, Zocchi MR. Lack of the leukocyte-associated Ig-like receptor-1 expression in high-risk chronic lymphocytic leukaemia results in the absence of a negative signal regulating kinase activation and cell division. Leukemia 2008; 22:980-8; PMID:18288129; http://dx.doi.org/10.1038/leu.2008.21
   PubMed Web of Science ®Google Scholar
• Poggi A, Pellegatta F, Leone BE, Moretta L, Zocchi MR. Engagement of the leukocyte-associated Ig-like receptor-1 induces programmed cell death and prevents NF-kappaB nuclear translocation in human myeloid leukemias. Eur J Immunol 2000; 30:2751-8; PMID:11069054; http://dx.doi.org/10.1002/1521-4141(200010)30:10%3c2751::AID-IMMU2751%3e3.0.CO;2-L
   PubMed Web of Science ®Google Scholar
• Zocchi MR, Pellegatta F, Pierri I, Gobbi M, Poggi A. Leukocyte-associated Ig-like receptor-1 prevents granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1/PKB alpha activation in primary acute myeloid leukemia cells. Eur J Immunol 2001; 31:3667-75; PMID:11745387; http://dx.doi.org/10.1002/1521-4141(200112)31:12%3c3667::AID-IMMU3667%3e3.0.CO;2-G
   PubMed Web of Science ®Google Scholar
• Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, Levine JE, Wang J, Hahn WC, Gilliland DG, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 2006; 442:818-22; PMID:16862118; http://dx.doi.org/10.1038/nature04980
   PubMed Web of Science ®Google Scholar
• Somervaille TC, Cleary ML. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 2006; 10:257-68; PMID:17045204; http://dx.doi.org/10.1016/j.ccr.2006.08.020
   PubMed Web of Science ®Google Scholar
• Yan M, Kanbe E, Peterson LF, Boyapati A, Miao Y, Wang Y, Chen IM, Chen Z, Rowley JD, Willman CL, et al. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat Med 2006; 12:945-9; PMID:16892037; http://dx.doi.org/10.1038/nm1443
   PubMed Web of Science ®Google Scholar
• Sugihara E, Shimizu T, Kojima K, Onishi N, Kai K, Ishizawa J, Nagata K, Hashimoto N, Honda H, Kanno M, et al. Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor. Oncogene 2011; PMID:21986948
   PubMed Web of Science ®Google Scholar
• Turner L, Lavstsen T, Berger SS, Wang CW, Petersen JE, Avril M, Brazier AJ, Freeth J, Jespersen JS, Nielsen MA, et al. Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature 2013; 498:502-5; PMID:23739325; http://dx.doi.org/10.1038/nature12216
   PubMed Web of Science ®Google Scholar
• Frei AP, Jeon OY, Kilcher S, Moest H, Henning LM, Jost C, Pluckthun A, Mercer J, Aebersold R, Carreira EM, et al. Direct identification of ligand-receptor interactions on living cells and tissues. Nat Biotech 2012; 30:997-1001; PMID:22983091; http://dx.doi.org/10.1038/nbt.2354
   PubMed Web of Science ®Google Scholar
• Xu M, Zhao R, Zhao ZJ. Identification and characterization of leukocyte-associated Ig-like receptor-1 as a major anchor protein of tyrosine phosphatase SHP-1 in hematopoietic cells. J Biol Chem 2000; 275:17440-6; PMID:10764762; http://dx.doi.org/10.1074/jbc.M001313200
   PubMed Web of Science ®Google Scholar
• Eklund EA, Goldenberg I, Lu Y, Andrejic J, Kakar R. SHP1 protein-tyrosine phosphatase regulates HoxA10 DNA binding and transcriptional repression activity in undifferentiated myeloid cells. J Biol Chem 2002; 277:36878-88; PMID:12145285; http://dx.doi.org/10.1074/jbc.M203917200
   PubMed Web of Science ®Google Scholar
• Verbrugge A, de Ruiter T, Geest C, Coffer PJ, Meyaard L. Differential expression of leukocyte-associated Ig-like receptor-1 during neutrophil differentiation and activation. J Leukoc Biol 2006; 79:828-36; PMID:16461736; http://dx.doi.org/10.1189/jlb.0705370
   PubMed Web of Science ®Google Scholar
• Nihal M Heiba SAE. SHP-1 expression in chronic myeloid leukemia ( clinical significance and impact on response to imatinib treatment). Egypt J Haematol 2013; 38:84-9
   Google Scholar
• Tibaldi E, Brunati AM, Zonta F, Frezzato F, Gattazzo C, Zambello R, Gringeri E, Semenzato G, Pagano MA, Trentin L. Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia 2011; 25:1768-81; PMID:21701493; http://dx.doi.org/10.1038/leu.2011.152
   PubMed Web of Science ®Google Scholar
• Tapley P, Shevde NK, Schweitzer PA, Gallina M, Christianson SW, Lin IL, Stein RB, Shultz LD, Rosen J, Lamb P. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice. Exp Hematol 1997; 25:122-31; PMID:9015212
   PubMed Web of Science ®Google Scholar
• Jiao H, Yang W, Berrada K, Tabrizi M, Shultz L, Yi T. Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction. Exp Hematol 1997; 25:592-600; PMID:9216734
   PubMed Web of Science ®Google Scholar
• Wu C, Guan Q, Wang Y, Zhao ZJ, Zhou GW. SHP-1 suppresses cancer cell growth by promoting degradation of JAK kinases. J Cell Biochem 2003; 90:1026-37; PMID:14624462; http://dx.doi.org/10.1002/jcb.10727
   PubMed Web of Science ®Google Scholar
• Lorenz U, Bergemann AD, Steinberg HN, Flanagan JG, Li X, Galli SJ, Neel BG. Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1. J Exp Med 1996; 184:1111-26; PMID:9064328; http://dx.doi.org/10.1084/jem.184.3.1111
   PubMed Web of Science ®Google Scholar
• Paulson RF, Vesely S, Siminovitch KA, Bernstein A. Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nat Genet 1996; 13:309-15; PMID:8673130; http://dx.doi.org/10.1038/ng0796-309
   PubMed Web of Science ®Google Scholar
• Koyama M, Oka T, Ouchida M, Nakatani Y, Nishiuchi R, Yoshino T, Hayashi K, Akagi T, Seino Y. Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation. Lab Invest 2003; 83:1849-58; PMID:14691303; http://dx.doi.org/10.1097/01.LAB.0000106503.65258.2B
   PubMed Web of Science ®Google Scholar
• Uhm KO, Lee ES, Lee YM, Park JS, Kim SJ, Kim BS, Kim HS, Park SH. Differential methylation pattern of ID4, SFRP1, and SHP1 between acute myeloid leukemia and chronic myeloid leukemia. J Korean Med Sci 2009; 24:493-7; PMID:19543515; http://dx.doi.org/10.3346/jkms.2009.24.3.493
   PubMed Web of Science ®Google Scholar
• Gauffin F, Diffner E, Gustafsson B, Nordgren A, Wingren AG, Sander B, Persson JL, Gustafsson B. Expression of PTEN and SHP1, investigated from tissue microarrays in pediatric acute lymphoblastic, leukemia. Pediat Hematol Oncol 2009; 26:48-56; PMID:19206008; http://dx.doi.org/10.1080/08880010802625530
   PubMed Web of Science ®Google Scholar
• Bard-Chapeau EA, Li S, Ding J, Zhang SS, Zhu HH, Princen F, Fang DD, Han T, Bailly-Maitre B, Poli V, et al. Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. Cancer Cell 2011; 19:629-39; PMID:21575863; http://dx.doi.org/10.1016/j.ccr.2011.03.023
   PubMed Web of Science ®Google Scholar
• Leal M, Sapra P, Hurvitz SA, Senter P, Wahl A, Schutten M, Shah DK, Haddish-Berhane N, Kabbarah O. Antibody-drug conjugates: an emerging modality for the treatment of cancer. Annal New York Acad Sci 2014; 1321:41-54; PMID:25123209; http://dx.doi.org/10.1111/nyas.12499
   PubMed Web of Science ®Google Scholar
• Gill S, June CH. Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies. Immunol Rev 2015; 263:68-89; PMID:25510272; http://dx.doi.org/10.1111/imr.12243
   PubMed Web of Science ®Google Scholar